Metabolic, hemodynamic, and cardiac effects of captopril in young, spontaneously hypertensive rats

American Journal of Hypertension

Volumn 12, Issue 6, 1999, Pages 581-589

  Swislocki, A L M ^a,b   Kinney Lapier, T L ^c   Khuu, D T ^a   Fann, K Y ^a   Tait, M ^a   Rodnick, K J ^c  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c IDAHO STATE UNIVERSITY   (United States)

Author keywords

Captopril; Cardiac metabolism; Glucose tolerance; Insulin action; Spontaneously hypertensive rat

Indexed keywords

3 HYDROXYACYL COENZYME A DEHYDROGENASE; CAPTOPRIL; CITRATE SYNTHASE; FATTY ACID; GLUCOSE; HEART ENZYME; HEXOKINASE; INSULIN; WATER;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD PRESSURE; CONTROLLED STUDY; ENZYME ACTIVITY; FATTY ACID OXIDATION; GROWTH RATE; HEART LEFT VENTRICLE MASS; HEART MUSCLE METABOLISM; HEMODYNAMICS; MALE; NONHUMAN; ORAL DRUG ADMINISTRATION; ORAL GLUCOSE TOLERANCE TEST; PRIORITY JOURNAL; RAT; SPONTANEOUSLY HYPERTENSIVE RAT; STRAIN DIFFERENCE;

ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ANIMALS; BLOOD PRESSURE; BODY WEIGHT; CAPTOPRIL; GLUCOSE TOLERANCE TEST; HEART; HEMODYNAMIC PROCESSES; INSULIN; MALE; MYOCARDIUM; RATS; RATS, INBRED SHR; RATS, INBRED WKY;

EID: 0344731322     PISSN: 08957061     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0895-7061(99)00012-6     Document Type: Article

References (49)

1. Frohlich E.D., Chobanian A.V., Devereux R.B. The heart in hypertension. N Engl J Med. 327:1992;998-1008.
2. Swislocki A.L.M., Tsuzuki A. Insulin resistance and hypertension glucose intolerance, hyperinsulinemia, and elevated free fatty acids in the lean spontaneously hypertensive rat . Am J Med Sci. 306:1993;282-286.
3. Reaven G.M., Lithell H., Landsberg L. Hypertension and associated metabolic abnormalities - the role of insulin resistance and the sympathoadrenal system. N Engl J Med. 334:1996;374-381.
4. Swislocki A.L.M., Hoffman B.B., Reaven G.M. Insulin resistance, glucose intolerance, and hyperinsulinemia in patients with hypertension. Am J Hypertens. 2:1989;419-423.
5. Hulman S., Falkner B., Chen Y.Q. Insulin resistance in the spontaneously hypertensive rat. Metabolism. 40:1991;359-361.
6. Reaven G.M., Chang H., Hoffman B.B., et al. Resistance to insulin stimulated glucose uptake in adipocytes isolated from spontaneously hypertensive rats. Diabetes. 32:1989;217-221.
7. Bishop S.P., Altschuld R.A. Increased glycolytic metabolism in cardiac hypertrophy and congestive failure. Am J Physiol. 218:1970;153-159.
8. Christie M.E., Rodgers R.L. Altered glucose and fatty acid oxidation in the hearts of the spontaneously hypertensive rat. J Mol Cell Cardiol. 26:1994;1371-1375.
9. Nuutila P., Maki M., Laine H., et al. Insulin action on heart and skeletal muscle glucose uptake in essential hypertension. J Clin Invest. 96:1995;1003-1009.
10. Richer C., Giroux B., Plouin P.F., et al. Captopril pharmacokinetics, antihypertensive and biological effects in hypertensive patients . Br J Clin Pharmacol. 17:1984;243-250.
11. Pollare T., Lithell H., Berne C. A comparison of the effects of hydrochlorothiazide and captopril on glucose and lipid metabolism in patients with hypertension. N Engl J Med. 321:1989;868-873.
12. Masuo K., Mikami H., Ogihara T., et al. Metabolic effects of long-term treatments with nifedipine-retard and captopril in young hypertensive patients. Am J Hypertens. 10:1997;600-610.
13. Richer C., Doussau M.-P., Guidicelli J.-F. Systemic and regional hemodynamic profile of five angiotensin I converting enzyme inhibitors in the spontaneously hypertensive rat. Am J Cardiol. 59:1987;12D-17D.
14. Frohlich ED, Horinaka S: Cardiac and aortic effects of angiotensin converting enzyme inhibitors. Hypertension 1991;18(suppl II):II-2-II-7.
15. Pfeffer J.M., Pfeffer M.A., Mirsky I., et al. Regression of left ventricular hypertrophy and prevention of left ventricular function by captopril in the spontaneously hypertensive rat. Proc Natl Acad Sci. 79:1982;3310-3314.
16. Takasaki I., Shionoiri H., Hiroto S., et al. Long-term captopril therapy with no effect on glucose metabolism in patients with essential hypertension. Am J Hypertens. 1:1988;217S-220S.
17. 2+ channel antagonists, and alpha-adrenergic blockers on glucose and lipid metabolism in NIDDM patients with hypertension. Diabetes. 44:1995;665-671.
18. Bunag R.D. Validation in awake rats of a tail-cuff method for measuring systolic pressure. J Appl Physiol. 34:1973;279-282.
19. Hansen C.A., Sidell B.D. Atlantic hagfish cardiac muscle metabolic basis of tolerance to anoxia . Am J Physiol. 244:1983;R356-R362.
20. Rodnick K.J., Sidell B.D. Cold acclimation increases carnitine palmitoyltransferase I activity in oxidative muscle of striped bass. Am J Physiol. 266:1994;R405-R412.
21. Crabtree B., Newsholme E.A. The activities of phosphorylase, hexokinase, phosphofuctokinase, lactate dehydrogenase and the glycerol 3-phosphate dehydrogenases in muscles from vertebrates and invertebrates. Biochem J. 126:1972;49-58.
22. Keppel G. Design and Analysis. 1991;Prentice Hall, New Jersey.
23. Levens N.R., Peach M.J., Vaughan E.D. Jr. Responses of blood pressure and angiotensin-converting enzyme activity to acute captopril administration in normotensive and hypertensive rats. Endocrinology. 108:1981;536-544.
24. Higashimori K., Nakamaru M., Tabuchi Y., et al. Angiotensin converting enzyme inhibitors suppress the vascular renin-angiotensin system of spontaneously hypertensive rats. Am J Hypertens. 4:1991;56S-59S.
25. Zhu Y.-C., Stauss H.M., Bao G., et al. Role of bradykinin in the antihypertensive and cardioprotective actions of converting enzyme inhibitors. Can J Physiol Pharmacol. 73:1995;827-831.
26. Tamura K., Umemura S., Nyui N., et al. Tissue-specific regulation of angiotensinogen gene expression in spontaneously hypertensive rats. Hypertension. 27:1996;1216-1223.
27. Ohashi H., Matsunaga M., Yoshid H., et al. Prevention of nephrosclerosis and cardiac hypertrophy by captopril treatment of spontaneously hypertensive rats. Jpn Circ J. 50:1986;140-146.
28. Kuzuo H., Honda M., Ishinaga Y., et al. Angiotensin converting enzyme inhibitor, captopril, inhibits cardiac hypertrophy without changing collagen types and concentration in spontaneously hypertensive rats. Clin Exp Pharmacol Physiol. 20:1993;253-260.
29. Unger T., Mattfeldt, Lamberty V., et al. Effect of early onset of angiotensin converting enzyme inhibition on myocardial capillaries. Hypertension. 20:1992;478-482.
30. Lopaschuk G.D., Belke D.D., Gamble J., et al. Regulation of fatty acid oxidation in the mammalian heart in health and disease. Biochim Biophys Acta. 1213:1994;263-276.
31. Farmer B.B., Harris R.A., Jolly W.W., et al. Studies on the cardiomegaly of the spontaneously hypertensive rat. Circ Res. 35:1974;102-111.
32. Bing O.H.L., Wiegner A.W., Brooks W.W., et al. Papillary muscle structure-function relations in the aging spontaneously hypertensive rat. Clin Exp Hypertens. 10:1988;37-58.
33. Bing O.H.L., Brooks W.W., Wiegner A.W. Myocardial mechanics in two models of pressure overload hypertrophy. Tarazi R.C., Dunbar J.B. Perspectives in Cardiovascular Research. Vol 8:1983;167-177 Raven, New York.
34. Pfeffer M.A., Pfeffer J.M., Frohlich E.D. Pumping ability of the hypertrophying left ventricle of the spontaneously hypertensive rat. Circ Res. 38:1976;423-429.
35. Randle P.J., Garland P.B., Hales C.N., et al. The glucose fatty-acid cycle its role in insulin sensitivity and the metabolic disturbances of diabetes mellitus . Lancet. i:1963;785-794.
36. Maki M.T., Haaparanta M., Nuutila P., et al. Free fatty acid uptake in the myocardium and skeletal muscle using fluorine-18-fluoro-6-thia-heptadecanoic acid. J Nucl Med. 39:1998;1320-1327.
37. Rodrigues B., Cam M.C., McNeill J.H. Metabolic disturbances in diabetic cardiomyopathy. Mol Cell Biochem. 180:1998;53-57.
38. Nuutila P., Koivisto V.A., Knuuti J., et al. Glucose-free fatty acid cycle operates in human heart and skeletal muscle in vivo. J Clin Invest. 89:1992;1767-1774.
39. Yki-Jarvinen H., Puhakainen I., Saloranta C., Taskinen M.-R. Demonstration of a novel feedback mechanism between FFA oxidation from intracellular and intravascular sources. Am J Physiol. 260:1991;E680-E689.
40. Kashiwaya Y., Sato K., Tsuchiya N., et al. Control of glucose utilization in working perfused rat heart. J Biol Chem. 269:1994;25502-25514.
41. Paternostro G., Clarke K., Heath J., et al. Decreased GLUT-4 mRNA content and insulin-sensitive deoxyglucose uptake show insulin resistance in the hypertensive rat heart. Cardiovasc Res. 30:1995;205-211.
42. Bursztyn M., Ben-Ishay D., Gutman A. Insulin resistance in spontaneously hypertensive rats but not in secondary hypertension of the rat, deoxycorticosterone-salt or renal vascular hypertension. J Hypertens. 10:1992;137-142.
43. Rennie M.J., Holloszy J.O. Inhibition of glucose uptake and glycogenolysis by availability of oleate in well-oxygenated perfused skeletal muscle. Biochem J. 168:1977;161-170.
44. 1 receptors. Eur J Pharmacol. 282:1995;77-86.
45. Swislocki A.L.M., Goodman M.N., Khuu D.T., et al. Insulin and hypertension in vivo and in vitro insulin action in skeletal muscle in spontaneously hypertensive and Wistar Kyoto rats . Am J Hypertens. 10:1997;1159-1164.
46. Ben Bachir-Lamrini L., Sempore B., Mayet M.-H., et al. Evidence of a slow-to-fast fiber type transition in skeletal muscle from spontaneously hypertensive rats. Am J Physiol. 258:1990;R352-R357.
47. Gray S.D., Carlsen R.C., Atherley R. Effect of chronic blood pressure reduction on soleus muscle contractile properties in spontaneously hypertensive rats. Am J Physiol. 267:1994;R740-R746.
48. Donnelly R. Angiotensin-converting enzyme inhibitors and insulin sensitivity metabolic effects in hypertension, diabetes, and heart failure . J Cardiovasc Pharmacol. 20:(suppl 11):1992;S38-S44.
49. Carvalho C.R.O., Thironc A.C.P., Gontijo J.A.R., et al. Effect of captopril, losartan, and bradykinin on early steps of insulin action. Diabetes. 46:1997;1950-1957.